RATIONALE: Acute nicotine replacement treatments (NRTs) are disliked or misused, leading to insufficient nicotine intake and poor outcome. Patches provide steady nicotine but are slow and passive. Combining systems may improve efficacy with acute NRTs tailored for compliance. OBJECTIVE: To test initial reactions to and use preferences among combinations of NRTs. MATERIALS AND METHODS: Smokers (n=27) tested fourcombination NRTs in a 5-day crossover trial: 2/4-mg gum + 15-mg patch (G/P), 2/4-mg lozenges + 15-mg patch (L/P), inhaler + 15-mg patch (I/P), and 10 mg + 15-mg patches (P/P). Subjects rated an NRT combination each day after 5-6 h of use and ranked among the NRTs after testing all treatments. RESULTS: Double-patches (P/P) were ranked highest for "ease of use", "safety", and "use in public". However, for "help to quit", 70% preferred some form of acute-patch combination (A/P) compared to 30% choosing P/P. For "use under stress" (an immediate need), 93% preferred A/P systems compared to 7% choosing P/P. L/P ranked lowest for "ease of use", I/P and L/P were lowest on "safety", and I/P ranked lowest for "use in public". Expectations of NRTs changed with test experience for patches (better) and lozenges (worse). CONCLUSIONS: In brief testing, all combinations were acceptable. P/P was favored for ease, safety, and public use, but a majority chose A/P systems for help in quitting and use under stress. Combined use is viable and needs to be made known and accessible to smokers.
RCT Entities:
RATIONALE: Acute nicotine replacement treatments (NRTs) are disliked or misused, leading to insufficient nicotine intake and poor outcome. Patches provide steady nicotine but are slow and passive. Combining systems may improve efficacy with acute NRTs tailored for compliance. OBJECTIVE: To test initial reactions to and use preferences among combinations of NRTs. MATERIALS AND METHODS: Smokers (n=27) tested four combination NRTs in a 5-day crossover trial: 2/4-mg gum + 15-mg patch (G/P), 2/4-mg lozenges + 15-mg patch (L/P), inhaler + 15-mg patch (I/P), and 10 mg + 15-mg patches (P/P). Subjects rated an NRT combination each day after 5-6 h of use and ranked among the NRTs after testing all treatments. RESULTS: Double-patches (P/P) were ranked highest for "ease of use", "safety", and "use in public". However, for "help to quit", 70% preferred some form of acute-patch combination (A/P) compared to 30% choosing P/P. For "use under stress" (an immediate need), 93% preferred A/P systems compared to 7% choosing P/P. L/P ranked lowest for "ease of use", I/P and L/P were lowest on "safety", and I/P ranked lowest for "use in public". Expectations of NRTs changed with test experience for patches (better) and lozenges (worse). CONCLUSIONS: In brief testing, all combinations were acceptable. P/P was favored for ease, safety, and public use, but a majority chose A/P systems for help in quitting and use under stress. Combined use is viable and needs to be made known and accessible to smokers.
Authors: Saul Shiffman; Carolyn M Dresler; Peter Hajek; Simon J A Gilburt; Darren A Targett; Kenneth R Strahs Journal: Arch Intern Med Date: 2002-06-10
Authors: S J Leischow; S N Valente; A L Hill; P S Otte; M Aickin; T Holden; E Kligman; G Cook Journal: Exp Clin Psychopharmacol Date: 1997-02 Impact factor: 3.157
Authors: Elbert D Glover; Penny N Glover; Mikael Franzon; C Rollynn Sullivan; Connie C Cerullo; Robert M Howell; Gordon G Keyes; Fredrik Nilsson; Gerald R Hobbs Journal: Nicotine Tob Res Date: 2002-11 Impact factor: 4.244
Authors: Elizabeth S Hawes; Sofía Mildrum Chana; Alexandra Faust; Julianne C Baker; Peter S Hendricks; Andres Azuero; Adrienne C Lahti; Matthew J Carpenter; Karen L Cropsey Journal: Front Psychiatry Date: 2022-06-21 Impact factor: 5.435
Authors: Ned L Cooney; Judith L Cooney; Bridget L Perry; Michael Carbone; Emily H Cohen; Howard R Steinberg; David T Pilkey; Kevin Sevarino; Cheryl A Oncken; Mark D Litt Journal: Addiction Date: 2009-06-22 Impact factor: 6.526
Authors: Matthew J Carpenter; Bianca F Jardin; Jessica L Burris; Amanda R Mathew; Robert A Schnoll; Nancy A Rigotti; K Michael Cummings Journal: Drugs Date: 2013-04 Impact factor: 9.546
Authors: Chelsea M Cox; Jennifer C Westrick; Danielle E McCarthy; Matthew J Carpenter; Amanda R Mathew Journal: J Stud Alcohol Drugs Date: 2022-01 Impact factor: 2.582